Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HALO Pilot: Heparin in Septic Shock
NCT01648036Phase 2Completed
- Sponsor
- University of Manitoba
- Start
- Jul 2012
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin in septic shock, sponsored by University of Manitoba. Started Jul 2012; status: completed.
02
Drugs
heparin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT01648036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01648036.